GO:1904976 cellular response to bleomycin: DNA Damage Response, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904976 (cellular response to bleomycin) describes any change in a cell's state or activity caused by a bleomycin stimulus, including movement, secretion, enzyme production and gene expression.
• Bleomycin is a radiomimetic anticancer drug that binds DNA and, in the presence of iron and oxygen, generates reactive oxygen species that cause single- and double-strand breaks.
• Cellular responses to bleomycin include DNA damage signaling, senescence, ferroptosis resistance, epithelial cell priming, and macrophage-driven inflammation and fibrosis [1,4,5].
• Bleomycin is the most widely used experimental agent to model pulmonary fibrosis in rodents, making GO:1904976 central to fibrosis research [1,2,3,6].
• Key genes and pathways implicated in the cellular response to bleomycin include TP53, YAP/TAZ, IL-6/STAT3, Piezo1, Six1 and ferroptosis-related genes [1,3,4,5,8].
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal testing of candidate genes in bleomycin response and fibrosis [1,4,5].
Description
GO:1904976, cellular response to bleomycin, is a Gene Ontology biological process term that captures any process resulting in a change in state or activity of a cell as a result of a bleomycin stimulus. Bleomycin is a glycopeptide anticancer antibiotic that binds DNA and, in the presence of iron and oxygen, generates reactive oxygen species that produce single- and double-strand breaks. Because of this radiomimetic DNA-damaging activity, bleomycin is used both as a chemotherapeutic agent and as the standard experimental inducer of pulmonary fibrosis in animal models [1,2,6]. Understanding how cells respond to bleomycin is therefore important for cancer pharmacology, DNA repair biology and fibrotic disease research [1,7]. The cellular response to bleomycin is not a single pathway but a coordinated set of processes including DNA damage sensing, cell-cycle checkpoint activation, senescence, apoptosis, ferroptosis resistance, inflammatory cytokine secretion and mechanotransduction [1,3,4,5,8]. In the lung, bleomycin injury triggers alveolar epithelial cell senescence and macrophage-mediated inflammation that drive fibrosis [1,4]. Multiple stromal populations, rather than epithelial-to-mesenchymal transition, contribute to the fibrotic response in bleomycin models. For researchers, GO:1904976 provides a structured framework to annotate genes and pathways that mediate cellular reactions to bleomycin. It connects mechanistic studies of DNA damage and senescence to translational work on idiopathic pulmonary fibrosis and anticancer drug resistance [2,3,5,7].
cellular response to bleomycin At A Glance
| GO ID | GO:1904976 |
|---|---|
| GO term | cellular response to bleomycin |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Definition | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bleomycin stimulus. |
| Major function | Cellular sensing and response to bleomycin-induced DNA damage and oxidative stress, including DNA repair, checkpoint activation, senescence, apoptosis, ferroptosis resistance and inflammatory signaling [1,4,5,7]. |
| Stimulus | Bleomycin, a radiomimetic glycopeptide anticancer drug that binds DNA and generates reactive oxygen species. |
| Representative cell types | Alveolar epithelial cells, lung fibroblasts, macrophages and group 2 innate lymphoid cells [1,3,4,5,8]. |
| Disease relevance | Idiopathic pulmonary fibrosis, drug-induced lung injury, cancer chemotherapy response and resistance [1,2,3,7]. |
What Is GO:1904976?
In our own words, GO:1904976 (cellular response to bleomycin) refers to any process that changes the state or activity of a cell in response to a bleomycin stimulus. This includes changes in cell movement, secretion, enzyme production, gene expression and other cellular activities. The term is a biological_process in the Gene Ontology and is defined by the QuickGO definition: any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bleomycin stimulus. It has no synonyms in QuickGO. The term is distinct from organism-level or tissue-level responses because it is specifically cell-centric, and it is triggered by bleomycin rather than by other DNA-damaging agents.
Why Is cellular response to bleomycin Important in Cell Biology?
GO:1904976 is important because bleomycin is both a clinically used anticancer drug and the most widely employed experimental agent for modeling pulmonary fibrosis [1,2,7]. Cellular responses to bleomycin determine whether a cell survives, senesces, dies by apoptosis or ferroptosis, or secretes inflammatory mediators that reshape the tissue microenvironment [1,4,5]. These responses are central to understanding drug resistance in cancer and to developing therapies for fibrotic lung disease [2,3,7].
• Bleomycin is a radiomimetic anticancer drug whose cellular effects include DNA double-strand breaks and oxidative damage.
• Cellular response to bleomycin underlies the standard rodent model of pulmonary fibrosis used in translational research [1,2,6].
• Alveolar epithelial cell senescence in response to bleomycin contributes to fibrosis progression.
• Ferroptosis-resistant priming of alveolar epithelial cells modulates bleomycin-induced fibrosis.
• Macrophage-mediated pulmonary inflammation after bleomycin injury is regulated by YAP/TAZ.
• IL-6/STAT3 signaling in lung fibroblasts links bleomycin-induced senescence to fibrosis.
• Piezo1-mediated mechanotransduction regulates innate lymphoid cell function in lung pathogenicity.
• Bleomycin response pathways are relevant to chemotherapy resistance and drug discovery.
• Multiple stromal populations contribute to bleomycin-induced fibrosis without evidence for epithelial-to-mesenchymal transition.
• GO:1904976 provides a standardized annotation framework for genes involved in bleomycin response.
What Happens During cellular response to bleomycin?
Bleomycin uptake and DNA binding
In simple terms: Bleomycin enters the cell and attaches to DNA, setting the stage for damage.
Bleomycin is a glycopeptide antibiotic that binds DNA and, in the presence of iron and oxygen, generates reactive oxygen species that cause single- and double-strand breaks. This DNA binding is the initiating event of the cellular response to bleomycin and is the basis for its radiomimetic activity.
DNA damage sensing and checkpoint activation
In simple terms: The cell detects broken DNA and pauses its cycle to repair or respond.
Following bleomycin-induced DNA damage, cells activate DNA damage sensing pathways that can lead to cell-cycle arrest, senescence or apoptosis [4,7]. TP53 is a key regulator in this response, and Six1 promotes alveolar epithelium senescence in pulmonary fibrosis through regulating Tp53.
Senescence and apoptosis
In simple terms: Cells may permanently stop dividing or self-destruct after bleomycin damage.
Bleomycin exposure can induce cellular senescence in lung fibroblasts and alveolar epithelial cells, contributing to fibrosis [3,4]. Hesperidin inhibits lung fibroblast senescence via the IL-6/STAT3 signaling pathway to suppress pulmonary fibrosis, indicating that senescence is a modifiable component of the bleomycin response.
Ferroptosis resistance and cell survival
In simple terms: Some cells adapt to bleomycin by becoming resistant to a specific form of iron-dependent cell death.
Prophylactic quercetin administration attenuates pulmonary fibrosis via ferroptosis-resistant priming of alveolar epithelial cells, showing that ferroptosis resistance is part of the cellular response to bleomycin. This suggests that modulating ferroptosis pathways can alter bleomycin-induced injury outcomes.
Inflammatory and mechanotransduction signaling
In simple terms: Damaged cells send signals that recruit immune cells and sense mechanical forces.
YAP/TAZ are crucial regulators of macrophage-mediated pulmonary inflammation and fibrosis after bleomycin-induced injury. Piezo1-mediated mechanotransduction regulates the translational activity, function and lung pathogenicity of group 2 innate lymphoid cells, linking mechanical cues to bleomycin-related lung responses. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial-to-mesenchymal transition, highlighting the diversity of cellular responders.
Key Genes Involved in GO:1904976 cellular response to bleomycin
The following genes and proteins have been experimentally implicated in the cellular response to bleomycin and related fibrotic processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TP53 | Regulates senescence and apoptosis in response to DNA damage | Six1 promotes alveolar epithelium senescence in pulmonary fibrosis through regulating Tp53 |
| YAP/TAZ | Regulate macrophage-mediated pulmonary inflammation and fibrosis | Crucial regulators after bleomycin-induced injury |
| IL-6 | Cytokine involved in fibroblast senescence signaling | Hesperidin inhibits lung fibroblast senescence via IL-6/STAT3 signaling |
| STAT3 | Transcription factor in senescence and fibrosis pathways | Part of IL-6/STAT3 signaling in bleomycin-induced fibrosis |
| Six1 | Promotes alveolar epithelium senescence via Tp53 | Target for pulmonary fibrosis studies |
| Piezo1 | Mechanotransduction regulator in innate lymphoid cells | Regulates translational activity and lung pathogenicity |
| Ferroptosis-related genes | Modulate iron-dependent cell death and resistance | Quercetin primes alveolar epithelial cells via ferroptosis resistance |
| Quercetin targets | Prophylactic administration attenuates fibrosis | Used to study ferroptosis-resistant priming |
| Hesperidin targets | Inhibit lung fibroblast senescence | Suppress pulmonary fibrosis via IL-6/STAT3 |
| Stromal cell markers | Identify multiple stromal populations in fibrosis | Show fibrosis without epithelial-to-mesenchymal transition |
| Macrophage markers | Mediate pulmonary inflammation after bleomycin | YAP/TAZ regulate macrophage function |
| Alveolar epithelial cell markers | Senescence and ferroptosis resistance [4,5] | Key responders in bleomycin injury [4,5] |
| Group 2 innate lymphoid cell markers | Regulate lung pathogenicity via Piezo1 | Mechanotransduction in bleomycin response |
| Fibroblast markers | Senescence and fibrosis progression | Hesperidin targets fibroblast senescence |
| DNA repair genes | Respond to bleomycin-induced DNA breaks | Central to cellular resistance mechanisms |
| Reactive oxygen species regulators | Mediate oxidative damage from bleomycin | Bleomycin generates ROS in presence of iron and oxygen |
| Inflammation mediators | Drive macrophage-mediated injury | YAP/TAZ regulate pulmonary inflammation |
| Mechanotransduction genes | Sense mechanical microenvironment [2,8] | Modulating fibrotic mechanical microenvironment for therapy |
How Is cellular response to bleomycin Regulated?
The cellular response to bleomycin is regulated at multiple levels. DNA damage signaling through TP53 controls senescence and apoptosis decisions. IL-6/STAT3 signaling modulates fibroblast senescence and fibrosis. YAP/TAZ regulate macrophage-mediated inflammation and fibrosis after bleomycin injury. Piezo1-mediated mechanotransduction regulates translational activity and function of group 2 innate lymphoid cells. The fibrotic mechanical microenvironment can be modulated for idiopathic pulmonary fibrosis therapy, indicating that mechanical cues regulate bleomycin responses. Ferroptosis resistance pathways also modulate alveolar epithelial cell survival after bleomycin exposure.
cellular response to bleomycin and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TP53 | Pulmonary fibrosis via alveolar epithelium senescence | Knockout or point-mutation in alveolar epithelial cells |
| YAP/TAZ | Macrophage-mediated pulmonary inflammation and fibrosis | Conditional knockout in macrophages |
| IL-6/STAT3 | Lung fibroblast senescence and fibrosis | Knockout or overexpression in lung fibroblasts |
| Piezo1 | Lung pathogenicity of group 2 innate lymphoid cells | Knockout or knock-in in innate lymphoid cells |
| Ferroptosis-related genes | Ferroptosis-resistant priming in pulmonary fibrosis | Overexpression or knockout in alveolar epithelial cells |
Idiopathic pulmonary fibrosis
Bleomycin-induced lung injury is the standard experimental model for idiopathic pulmonary fibrosis [1,2,6]. Cellular responses to bleomycin, including alveolar epithelial cell senescence, ferroptosis resistance and macrophage-mediated inflammation, contribute to fibrosis progression [1,4,5]. Modulating the fibrotic mechanical microenvironment is being explored as a therapeutic strategy for idiopathic pulmonary fibrosis.
Cancer chemotherapy and drug resistance
Bleomycin is an anticancer drug whose cellular effects include DNA damage and oxidative stress. Cellular resistance to bleomycin-A5 involves multiple mechanisms, and understanding these pathways is important for optimizing chemotherapy. The cellular response to bleomycin therefore has direct implications for cancer treatment outcomes.
Drug-induced lung injury
Bleomycin treatment can cause pulmonary toxicity and fibrosis in patients, making the cellular response to bleomycin clinically relevant beyond oncology [1,2]. Studies using bleomycin-induced injury models have identified YAP/TAZ, IL-6/STAT3 and Piezo1 as potential targets for mitigating lung injury [1,3,8].
From cellular response to bleomycin-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X mediate bleomycin-induced senescence? | CRISPR knockout in alveolar epithelial cells or fibroblasts |
| Does a specific point mutation in TP53 alter bleomycin response? | Point-mutation knock-in in lung epithelial cells |
| Does overexpression of a ferroptosis regulator protect against bleomycin injury? | Overexpression cell model in alveolar epithelial cells |
| Does YAP/TAZ in macrophages regulate bleomycin-induced inflammation? | Conditional knockout in macrophages |
| Does Piezo1 mechanotransduction affect innate lymphoid cell function after bleomycin? | Knockout or tagged knock-in in group 2 innate lymphoid cells |
| Does IL-6/STAT3 signaling modulate fibroblast senescence? | Knockout or overexpression in lung fibroblasts |
How to Study the cellular response to bleomycin Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA sequencing | Gene expression changes after bleomycin | Identify pathways and annotate GO:1904976 genes [3,4,5] |
| Senescence-associated beta-galactosidase staining | Cellular senescence | Assess fibroblast and epithelial senescence after bleomycin [3,4] |
| Ferroptosis assays | Iron-dependent cell death and resistance | Study ferroptosis-resistant priming |
| Calcium imaging | Piezo1-mediated mechanotransduction | Assess innate lymphoid cell function |
| Translational activity assays | Protein synthesis changes | Measure Piezo1 effects on translation |
| Bleomycin-induced lung injury model | Pulmonary inflammation and fibrosis | In vivo validation of candidate genes [1,6] |
| Macrophage functional assays | Inflammatory cytokine secretion | Study YAP/TAZ in macrophage-mediated inflammation |
| Biomaterial-based mechanical modulation | Fibrotic mechanical microenvironment | Therapeutic testing for idiopathic pulmonary fibrosis |
Transcriptomic profiling
RNA sequencing can identify gene expression changes in cells exposed to bleomycin, revealing pathways such as IL-6/STAT3, TP53 and ferroptosis-related genes [3,4,5]. This approach helps annotate genes to GO:1904976 by measuring changes in gene expression as a result of bleomycin stimulus.
Senescence and cell death assays
Senescence-associated beta-galactosidase staining, apoptosis assays and ferroptosis detection can quantify cellular outcomes after bleomycin exposure [3,4,5]. These methods are used to study how genes like Six1, TP53 and ferroptosis regulators affect cell fate [4,5].
Mechanotransduction and imaging
Piezo1-mediated mechanotransduction can be studied using calcium imaging, translational activity assays and lung pathogenicity models. Modulating the fibrotic mechanical microenvironment can be assessed with biomaterial-based systems.
In vivo bleomycin models
Rodent bleomycin-induced lung injury models are used to study pulmonary inflammation and fibrosis, including macrophage-mediated responses and stromal cell contributions [1,6]. These models are standard for translational research in idiopathic pulmonary fibrosis.
How CRISPR Can Be Used to Study GO:1904976 cellular response to bleomycin
Knockout
CRISPR knockout of candidate genes such as TP53, YAP/TAZ, IL-6, STAT3 or Piezo1 can test their causal role in the cellular response to bleomycin [1,3,4,8]. Knockout models help determine whether a gene is required for bleomycin-induced senescence, inflammation or fibrosis [1,4].
Point Mutation
Point-mutation knock-in can model specific amino acid changes in genes like TP53 to dissect domain-specific functions in bleomycin response. This approach is useful for separating DNA-binding, transactivation and senescence-regulatory activities.
Knock-in
Tagged knock-in of genes such as Piezo1 or YAP/TAZ allows tracking of protein localization and interaction dynamics during bleomycin exposure [1,8]. Knock-in reporters can also monitor transcriptional responses to bleomycin in live cells.
Overexpression
Overexpression of ferroptosis regulators or IL-6/STAT3 pathway components can test gain-of-function effects on bleomycin-induced fibrosis and senescence [3,5]. Overexpression models are particularly useful for studying protective or resistance mechanisms.
How EDITGENE Supports cellular response to bleomycin Research
Researchers studying cellular response to bleomycin-related genes often need to determine whether a candidate gene is causally involved in DNA damage sensing, senescence, ferroptosis resistance or fibrosis. EDITGENE provides CRISPR-based cell model services that enable precise genetic manipulation to answer these questions.
Contact EDITGENE today to design your custom CRISPR model for cellular response to bleomycin research.
Frequently Asked Questions About cellular response to bleomycin
What is GO:1904976 cellular response to bleomycin?
GO:1904976 is a Gene Ontology biological process term defined as any process that results in a change in state or activity of a cell as a result of a bleomycin stimulus, including changes in movement, secretion, enzyme production and gene expression.
What genes are involved in cellular response to bleomycin?
Genes implicated in cellular response to bleomycin include TP53, YAP/TAZ, IL-6, STAT3, Six1, Piezo1 and ferroptosis-related genes [1,3,4,5,8].
How does bleomycin cause DNA damage?
Bleomycin binds DNA and, in the presence of iron and oxygen, generates reactive oxygen species that cause single- and double-strand breaks.
Why is bleomycin used to model pulmonary fibrosis?
Bleomycin-induced lung injury is the standard experimental model for pulmonary fibrosis because it triggers alveolar epithelial cell senescence, inflammation and fibrosis [1,2,6].
What is the role of TP53 in bleomycin response?
TP53 regulates senescence and apoptosis in response to DNA damage, and Six1 promotes alveolar epithelium senescence in pulmonary fibrosis through regulating Tp53.
How do YAP/TAZ regulate bleomycin-induced inflammation?
YAP/TAZ are crucial regulators of macrophage-mediated pulmonary inflammation and fibrosis after bleomycin-induced injury.
What is the role of ferroptosis in bleomycin response?
Prophylactic quercetin administration attenuates pulmonary fibrosis via ferroptosis-resistant priming of alveolar epithelial cells, indicating ferroptosis resistance is part of the response.
How can CRISPR be used to study cellular response to bleomycin?
CRISPR knockout, point-mutation, knock-in and overexpression models can test causal roles of genes like TP53, YAP/TAZ and Piezo1 in bleomycin response [1,4,8].
What signaling pathways are involved in bleomycin-induced fibrosis?
IL-6/STAT3 signaling, YAP/TAZ, Piezo1 mechanotransduction and TP53 pathways are involved in bleomycin-induced fibrosis [1,3,4,8].
What methods are used to study cellular response to bleomycin?
RNA sequencing, senescence assays, ferroptosis assays, calcium imaging, translational activity assays and in vivo bleomycin models are commonly used [1,3,5,8].
Conclusion
GO:1904976 (cellular response to bleomycin) is a biologically and clinically important Gene Ontology term that encompasses DNA damage sensing, senescence, ferroptosis resistance, inflammatory signaling and mechanotransduction [1,3,4,5,7,8]. It is central to cancer pharmacology and pulmonary fibrosis research, where bleomycin is the standard experimental inducer [1,2,7]. CRISPR-based cell models, including knockout, point-mutation, knock-in and overexpression, provide powerful tools to dissect the causal roles of genes such as TP53, YAP/TAZ, IL-6/STAT3 and Piezo1 in this process [1,3,4,8]. Continued research using these models will advance therapeutic strategies for fibrotic lung disease and improve understanding of bleomycin resistance in cancer [2,5,7].
References
- 1. Mia MM et al.. 2025. YAP/TAZ are crucial regulators of macrophage-mediated pulmonary inflammation and fibrosis after bleomycin-induced injury.. Eur Respir J 65(6) PMID: 39915054
- 2. Li XN et al.. 2024. Modulating Fibrotic Mechanical Microenvironment for Idiopathic Pulmonary Fibrosis Therapy.. Adv Mater 36(50):e2407661 PMID: 39529565
- 3. Han D et al.. 2023. Hesperidin inhibits lung fibroblast senescence via IL-6/STAT3 signaling pathway to suppress pulmonary fibrosis.. Phytomedicine 112:154680 PMID: 36736168
- 4. Fan Y et al.. 2025. Six1 promotes alveolar epithelium senescence in pulmonary fibrosis through regulating Tp53.. Int Immunopharmacol 166:115554 PMID: 40991995
- 5. Qiao Y et al.. 2026. Prophylactic quercetin administration attenuates pulmonary fibrosis via ferroptosis-resistant priming of alveolar epithelial cells.. Redox Rep 31(1):2632434 PMID: 41697789
- 6. Rock JR et al.. 2011. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition.. Proc Natl Acad Sci U S A 108(52):E1475-83 PMID: 22123957
- 7. Aouida M et al.. 2010. A new twist in cellular resistance to the anticancer drug bleomycin-A5.. Curr Drug Metab 11(7):595-602 PMID: 20812903
- 8. Lim M et al.. 2025. Piezo1-mediated mechanotransduction regulates the translational activity, function and lung pathogenicity of group 2 innate lymphoid cells.. Signal Transduct Target Ther 10(1):269 PMID: 40841361
